Myriad Genetics (MYGN) EBT Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) EBT Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn | -161.54% |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn | 7.04% |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn | 9.39% |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn | 14.63% |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn | 56.92% |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn | 1.55% |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn | -27.03% |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn | -13.74% |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn | 3.82% |
| 10 | Myriad Genetics | 406.19 Mn | 281.79 Mn | 137.60 Mn | -15.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.99% |
| Dec 31, 2025 | 77.24% |
| Sep 30, 2025 | -23.58% |
| Jun 30, 2025 | -788.71% |
| Mar 31, 2025 | -13.51% |
| Dec 31, 2024 | -21.05% |
| Sep 30, 2024 | 65.36% |
| Jun 30, 2024 | 67.96% |
| Mar 31, 2024 | 50.76% |
| Dec 31, 2023 | 38.00% |
| Sep 30, 2023 | -38.46% |
| Jun 30, 2023 | -548.60% |
| Mar 31, 2023 | -99.24% |
| Dec 31, 2022 | -19.77% |
| Sep 30, 2022 | -211.06% |
| Jun 30, 2022 | -371.05% |
| Mar 31, 2022 | 46.77% |
| Dec 31, 2021 | 53.77% |
| Sep 30, 2021 | 191.08% |
| Jun 30, 2021 | 93.50% |